New Releases from NCBI BookshelfPasireotide (Signifor LAR): Indication: For the treatment of adult patients with acromegaly for whom surgery is not an option or has not been curative and who are inadequately controlled on treatment with another somatostatin analogue: Reimbursement Recommendation [Internet].​Pasireotide (Signifor LAR): Indication: For the treatment of adult patients with acromegaly for whom surgery is not an option or has not been curative and who are inadequately controlled on treatment with another somatostatin analogue: Reimbursement Recommendation [Internet].